相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。
Article
Rheumatology
Risk factors of impaired humoral response to COVID-19 vaccination in rituximab-treated patients
Jerome Avouac et al.
Summary: This study aimed to identify factors influencing the humoral response to COVID-19 vaccination in RTX-treated patients. The results showed that B cell depletion was the main contributing factor to the antibody response in these patients, and monitoring CD19 levels may help determine the optimal timing for vaccination.
RHEUMATOLOGY (2022)
Editorial Material
Rheumatology
Efficacy and tolerability of a third dose of an mRNA anti-SARS-CoV-2 vaccine in patients with rheumatoid arthritis with absent or minimal serological response to two previous doses
Kristin Schmiedeberg et al.
LANCET RHEUMATOLOGY (2022)
Article
Urology & Nephrology
SARS-CoV-2 Antibody Response After a Third Dose of the BNT162b2 Vaccine in Patients Receiving Maintenance Hemodialysis or Peritoneal Dialysis
Ilias Bensouna et al.
Summary: The effectiveness of a third dose of the BNT162b2 vaccine in patients undergoing dialysis treatment was investigated, and it was found that the third dose significantly increased antibody levels.
AMERICAN JOURNAL OF KIDNEY DISEASES (2022)
分享论文
